Skip to main content

Table 1 Analysis of patient population demographic data and associated medical problems

From: Investigation of homocysteine level after bariatric metabolic surgery, effect on vitamin B12 and folate levels

 

RYGB

SG

p = value

Total

Sex, n (%)

 Male

 Female

23 (21.7%)

83 (78.3%)

3 (15%)

17 (85%)

0.763

126

Body mass index, (mean ± SD), kg/m2

41.82 ± 5.93

38.8 ± 4.09

0.055

41.30 ± 5.75

Age, median (range), year

38 (22–72)

27 (18–62)

0.002

37 (18–72)

Tip 2 Diabetes Mellitus, n (%)

56 (52.83%)

6 (30%)

0.061

62 (49.21%)

Hypertension, n (%)

25 (23.58%)

2 (10%)

0.24

27 (21.43%)

Hypothyroidism, n (%)

16 (15.09%)

0

0.073

16 (12.7%)

Dyslipidemia, n (%)

57 (53.77%)

7 (35%)

0.148

64 (50.79%)

Chronic Obstructive Pulmonary Disease, n (%)

3 (2.83%)

0

> 0.999

3 (2.38%)

Asthma, n (%)

12 (11.32%)

0

0.211

12 (9.52%)

Polycystic Ovary Syndrome, n (%)

3 (2.83%)

0

0.178

3 (2.83%)

History of Cerebrovascular Event, n (%)

1 (0.94%)

2 (10%)

> 0.999

3 (2.83%)

History of Coronary Artery Disease, n (%)

5 (4.72%)

0

> 0.999

5 (3.97%)

Generalized Anxiety Disorder, n (%)

9 (8.49%)

2 (10%)

> 0.999

11 (8.73%)

Depression, n (%)

14 (13.21%)

1 (5%)

0.462

15 (11.9%)

Obsessive Compulsive Disorder, n (%)

4 (3.77%)

0

> 0.999

4 (3.17%)

Postoperative Complications, n (%)

2 (1.59%)

0

> 0.999

2 (1.59%)

Length of Hospitalization, median (range), day

2 (1–10)

2 (1–5)

0.025

2 (1–10)

  1. RYGB: Roux-en-Y Gastric Bypass, SG: Sleeve Gastrectomy, n: number, SD: Standard Deviation, kg: kilograms, m2: square meter